Surface Oncology, Inc.
Records under this name other than the patents Surface Oncology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Showing 1 to 9 of 9 · Back to Surface Oncology, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,650,441 | Anti-CD47 antibodies and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,803,016 | Anti-CD47 antibodies and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,570,201 | Anti-CD47 antibodies and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,312,783 | Antibody Molecules to CD73 and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,496,342 | Anti-CCR8 Antibodies and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,859,000 | ANTI-CCR8 Antibodies and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,793,637 | Antibodies That Bind CD39 and Uses Thereof Lapsed on the fee record Ended Oct 6, 2024 · High confidence | Lapsed on the fee record | Ended Oct 6, 2024 | High confidence |
| US 10,738,128 | Antibodies That Bind CD39 and Uses Thereof Lapsed on the fee record Ended Aug 11, 2024 · High confidence | Lapsed on the fee record | Ended Aug 11, 2024 | High confidence |
| US 10,442,858 | Anti-CD47 antibodies and methods of use Lapsed on the fee record Ended Oct 15, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 15, 2023 | From the USPTO record |